We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Immune Response Differentiates Malaria from Other Infections

By LabMedica International staff writers
Posted on 11 May 2017
Malaria affects around 200 million people around the world but its non-specific symptoms, coupled with a lack of access to testing facilities, mean it is difficult to distinguish from other infectious diseases.

Treating malaria promptly not only increases a patient's chances of survival, but also helps prevent the disease from spreading to more people and could ultimately speed up malaria diagnosis and treatment. More...
Analyzing a patient’s immune response could be central to quickly and accurately diagnosing malaria.

Scientists at Stanford University combine the data already available from 40 previous studies, bringing together more than 3,000 blood samples from patients with various infectious diseases. This included some from patients who were known to have malaria, some from patients with other common tropical diseases such as dengue, typhoid, or leishmaniasis, and some from healthy volunteers.

The team combined the data, which allowed them to study the activity of more than 6,000 different genes. They used a computer to trawl through 2,100 of the samples and look for patterns of gene expression. They found that a group of seven genes showed a different pattern of expression in patients with malaria, compared with healthy people and patients with other infectious diseases. Once the pattern of expression of these genes had been identified, the scientists tested it out on the remaining 900 samples from patients with different tropical diseases and from healthy people. They found that the pattern could distinguish malaria samples from the others with 96% accuracy.

Purvesh Khatri, PhD, an assistant professor and lead investigator of the study said, “We know that the immune system is able to deploy different tactics for fighting different infections such as bacteria, viruses and the malaria parasite. This study shows that we can detect signs of these differences by looking at which genes are being expressed, and we think it is possible to use this knowledge to speed up diagnosis and treatment.” The study was presented at the 27th European Congress of Clinical Microbiology and Infectious Diseases, held April 22-25, 2017, in Vienna, Austria.


Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gel Cards
DG Gel Cards
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.